+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service, By Product, By Phase, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 192 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5440526
Description Jump to:

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 8.18% from 2025 to 2030. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights

  • In 2024, the biorepository services segment dominated the market, accounting for a revenue share of 66.91%. The segment growth can be attributed to the rise in R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, which require effective storage, distribution, and processing solutions.
  • On the basis of the product segment, the market is segmented into preclinical products and clinical products. In 2024, the clinical products segment accounted for the largest revenue share of 63.40% in the clinical trial biorepository & archiving solutions market.
  • On the basis of phase segment, the market is segmented to preclinical, phase I, phase II, phase III, and phase IV. The preclinical segment accounted for the largest revenue share of 36.60% in 2024. The segment growth can be growing emphasis on data integrity & transparency.
  • North America clinical trial biorepository & archiving solutions market accounted for the largest share of 47.99% in 2024. The increase in the number of clinical trials and several market players in the region aiming to expand their existing services are further contributing to the growth of clinical trial biorepository & archiving solutions.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Product
1.2.3. Phase
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing number of pharmaceutical and biotechnology companies
3.2.1.2. Growing disease variation and prevalence
3.2.1.3. Increasing R&D investments
3.2.1.4. Growth in the CRO market
3.2.2. Market Restraint Analysis
3.2.2.1. Regulations for new drug development
3.2.2.2. Rising cost of clinical trials
3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis
4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
4.4. Biorepository Services
4.4.1. Biorepository Services Market, 2018 to 2030 (USD Million)
4.4.2. Warehousing & Storage
4.4.2.1. Warehousing & Storage Market, 2018 to 2030 (USD Million)
4.4.3. Transportation
4.4.3.1. Transportation Market, 2018 to 2030 (USD Million)
4.4.4. Sample Processing
4.4.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others Market, 2018 to 2030 (USD Million)
4.5. Archiving Solution Services
4.5.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
4.5.2. Database Indexing and Management
4.5.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
4.5.3. Scanning & Destruction
4.5.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)
Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis
5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product, 2018 - 2030
5.4. Preclinical Products
5.4.1. Preclinical Products Market, 2018 to 2030 (USD Million)
5.5. Clinical Products
5.5.1. Clinical Products Market, 2018 to 2030 (USD Million)
5.5.2. Human Tissue
5.5.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
5.5.3. Organs
5.5.3.1. Organs Market, 2018 to 2030 (USD Million)
5.5.4. Stem Cells
5.5.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
5.5.5. Other Biospecimens
5.5.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)
Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis
6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
6.4. Preclinical
6.4.1. Preclinical conditions Market, 2018 to 2030 (USD Million)
6.5. Phase I
6.5.1. Phase I Market, 2018 to 2030 (USD Million)
6.6. Phase II
6.6.1. Phase II Market, 2018 to 2030 (USD Million)
6.7. Phase III
6.7.1. Phase III Market, 2018 to 2030 (USD Million)
6.8. Phase IV
6.8.1. Phase IV Market, 2018 to 2030 (USD Million)
Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Share Analysis, 2023/24
8.3. Company Profiles
8.3.1. Medpace
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. American Type Culture Collection (ATCC)
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Cell&Co BioServices (Cryoport)
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Brooks Life Sciences (Azenta, Inc.)
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Patheon (Thermo Fisher Scientific, Inc.)
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Precision Medicine Group, LLC.
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Labcorp Drug Development
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Q2 Solutions
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. LabConnect
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Charles River Laboratories
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
Chapter 9 Key Recommendations
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 4 North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 5 North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 6 North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 7 U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 8 U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 10 Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 11 Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 12 Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 13 Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 14 Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 15 Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 16 Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 17 Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 18 Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 19 Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 20 UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 21 UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 22 UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 23 Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 24 Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 25 Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 26 France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 27 France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 28 France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 29 Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 30 Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 31 Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 32 Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 33 Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 34 Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 35 Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 36 Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 37 Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 38 Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 39 Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 40 Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 41 Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 42 Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 43 Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 48 Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 49 Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 50 Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 51 China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 52 China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 53 China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 54 India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 55 India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 56 India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 57 Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 58 Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 59 Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 60 South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 61 South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 62 South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 63 Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 64 Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 65 Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 66 Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 67 Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 68 Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 69 Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 70 Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 71 Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 72 Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 73 Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 74 Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 75 Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 76 Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 77 Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 78 Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 83 South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 84 South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 85 South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 89 UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 90 UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 91 UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 92 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 93 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 94 Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot 1
Fig. 13 Segment snapshot 2
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market outlook, 2023 (USD Billion)
Fig. 16 Ancillary market outlook, 2023 (USD Billion)
Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
Fig. 18 Porter’s five forces analysis
Fig. 19 PESTEL analysis
Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Regional Marketplace: Key Takeaways
Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Fig. Key country dynamics
Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key company categorization
Fig. 100 Service heat map analysis
Fig. 101 Strategic framework

Companies Mentioned

  • Medpace
  • American Type Culture Collection (ATCC)
  • Cell&Co BioServices (Cryoport)
  • Brooks Life Sciences (Azenta, Inc.)
  • Patheon (Thermo Fisher Scientific, Inc.)
  • Precision Medicine Group, LLC.
  • Labcorp Drug Development
  • Q2 Solutions
  • LabConnect
  • Charles River Laboratories

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.38 billion
Forecasted Market Value ( USD ) by 2030 $ 7.01 billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Clinical Trial Biorepository & Archiving Solutions Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Image

Clinical Trial Biorepository & Archiving Solutions Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
AI-based Clinical Trials Solution Provider Market Size, Share and Trends Analysis Report by Therapeutic Application, Clinical Trial Phase, End-use, and Region 2024-2030 - Product Image

AI-based Clinical Trials Solution Provider Market Size, Share and Trends Analysis Report by Therapeutic Application, Clinical Trial Phase, End-use, and Region 2024-2030

  • Report
  • 118 Pages
  • Global
From
Europe Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Indication (Oncology, Diabetes), Study Design, Service Type, Sponsor, Region, and Segment Forecasts, 2025-2030 - Product Image

Europe Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Indication (Oncology, Diabetes), Study Design, Service Type, Sponsor, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Europe
From
Clinical Data Analytics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Clinical Data Analytics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Virtual Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032 - Product Image

Virtual Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032

  • Report
  • 170 Pages
  • Global
From

About the Biorepository Market

The Clinical Trial Biorepository market is a subset of the biotechnology industry that focuses on the collection, storage, and distribution of biological samples for clinical trials. These samples are typically collected from patients and used to study the efficacy of new treatments and drugs. Clinical Trial Biorepositories are responsible for ensuring the quality and integrity of the samples, as well as providing secure storage and transportation of the samples. They also provide data management services to ensure that the data collected is accurate and up-to-date. The Clinical Trial Biorepository market is highly competitive, with many companies offering a variety of services. Some of the major players in the market include BioStorage Technologies, BioreclamationIVT, and Biorepositories.com. Other companies in the market include BioIVT, Biobanking Solutions, and BioVault Services. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.